In vitro and in vivo studies on the combination of Brequinar sodium (DUP-785; NSC 368390) with 5-fluorouracil; effects of uridine.

por Peters, G. J., Kraal, I., Pinedo, H. M.
Publicado 1992

Response of peritoneal solid tumours after intraperitoneal chemohyperthermia treatment with cisplatin or carboplatin.

por Los, G., van Vugt, M. J., Pinedo, H. M.
Publicado 1994

Activity of GR30921X (NSC 382057) and GR63178A (NSC D611615) in human ovarian cancer lines.

por Boven, E., Erkelens, C. A., Luning, M., Pinedo, H. M.
Publicado 1990

Drug resistance features and S-phase fraction as possible determinants for drug response in a panel of human ovarian cancer xenografts

por Kolfschoten, G M, Hulscher, T M, Pinedo, H M, Boven, E
Publicado 2000

Cyclosporin A and verapamil have different effects on energy metabolism in multidrug-resistant tumour cells.

por Broxterman, H. J., Pinedo, H. M., Schuurhuis, G. J., Lankelma, J.
Publicado 1990

The anti-tumour effects of the prodrugs N-l-leucyl-doxorubicin and vinblastine-isoleucinate in human ovarian cancer xenografts.

por Boven, E., Hendriks, H. R., Erkelens, C. A., Pinedo, H. M.
Publicado 1992

The influence of the schedule and the dose of gemcitabine on the anti-tumour efficacy in experimental human cancer.

por Boven, E., Schipper, H., Erkelens, C. A., Hatty, S. A., Pinedo, H. M.
Publicado 1993

Human tumour clonogenicity in agar is improved by cell-free ascites.

por Uitendaal, M. P., Hubers, H. A., McVie, J. G., Pinedo, H. M.
Publicado 1983

Comparison of monoclonal antibodies 17-1A and 323/A3: the influence of the affinity on tumour uptake and efficacy of radioimmunotherapy in human ovarian cancer xenografts.

por Kievit, E., Pinedo, H. M., Schlüper, H. M., Haisma, H. J., Boven, E.
Publicado 1996

Comparison of the pharmacokinetics, biodistribution and dosimetry of monoclonal antibodies OC125, OV-TL 3, and 139H2 as IgG and F(ab')2 fragments in experimental ovarian cancer.

por Molthoff, C. F., Pinedo, H. M., Schlüper, H. M., Nijman, H. W., Boven, E.
Publicado 1992

Enhanced transplantability of human ovarian cancer lines in cyclophosphamide-pretreated nude mice.

por Nauta, M. M., Boven, E., Schlüper, H. M., Erkelens, C. A., Pinedo, H. M.
Publicado 1986

Lobular panniculitis after subcutaneous administration of interleukin-2 (IL-2), and its exacerbation during intravenous therapy with IL-2.

por Baars, J. W., Coenen, J. L., Wagstaff, J., van der Valk, P., Pinedo, H. M.
Publicado 1992

DT-diaphorase activity in normal and neoplastic human tissues; an indicator for sensitivity to bioreductive agents?

por Smitskamp-Wilms, E., Giaccone, G., Pinedo, H. M., van der Laan, B. F., Peters, G. J.
Publicado 1995

p53 and P-glycoprotein are often co-expressed and are associated with poor prognosis in breast cancer.

por Linn, S. C., Honkoop, A. H., Hoekman, K., van der Valk, P., Pinedo, H. M., Giaccone, G.
Publicado 1996

CPT-11 sensitivity in relation to the expression of P170-glycoprotein and multidrug resistance-associated protein.

por Jansen, W. J., Hulscher, T. M., van Ark-Otte, J., Giaccone, G., Pinedo, H. M., Boven, E.
Publicado 1998

Cortisol is transported by the multidrug resistance gene product P-glycoprotein.

por van Kalken, C. K., Broxterman, H. J., Pinedo, H. M., Feller, N., Dekker, H., Lankelma, J., Giaccone, G.
Publicado 1993

A monoclonal antibody-beta-glucuronidase conjugate as activator of the prodrug epirubicin-glucuronide for specific treatment of cancer.

por Haisma, H. J., Boven, E., van Muijen, M., de Jong, J., van der Vijgh, W. J., Pinedo, H. M.
Publicado 1992

Functional detection of MDR1/P170 and MRP/P190-mediated multidrug resistance in tumour cells by flow cytometry.

por Feller, N., Kuiper, C. M., Lankelma, J., Ruhdal, J. K., Scheper, R. J., Pinedo, H. M., Broxterman, H. J.
Publicado 1995

Continuous infusion or subcutaneous injection of granulocyte-macrophage colony-stimulating factor: increased efficacy and reduced toxicity when given subcutaneously.

por Honkoop, A. H., Hoekman, K., Wagstaff, J., van Groeningen, C. J., Vermorken, J. B., Boven, E., Pinedo, H. M.
Publicado 1996

Enhanced therapeutic efficacy of 5'deoxy-5-fluorouridine in 5-fluorouracil resistant head and neck tumours in relation to 5-fluorouracil metabolising enzymes.

por Peters, G. J., Braakhuis, B. J., de Bruijn, E. A., Laurensse, E. J., van Walsum, M., Pinedo, H. M.
Publicado 1989